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Aldosterone makes human endothelium stiff and vulnerable.
Background. Aldosterone has long been known to control
water and electrolyte balance by acting on mineralocorticoid re-
ceptors in kidney. However, recent studies identified these clas-
sic receptors also in the vascular system. Indeed, aldosterone
alters structure and function of human endothelium. We ap-
plied nanotechniques to detect these changes.
Methods. Experiments were performed in cultured monolay-
ers of human umbilical vein endothelial cells (HUVECs). Ten
nanomoles per liter aldosterone or solvent (control) was added
to the culture medium for 72 hours. Atomic force microscopy
(AFM) was used as a nanotool that physically interacts with the
cell surface. In the monolayer we measured cell volume, apical
cell surface, and cell stiffness.
Results. Volume, apical surface area, and stiffness of indi-
vidual cells increased in response to aldosterone by 18% (P <
0.05), 64% (P < 0.001), and 78% (P < 0.01), respectively. Imag-
ing of the cell-to-cell contacts disclosed gaps in response to
aldosterone. Furthermore, underneath the monolayer we de-
tected an aldosterone-induced increase of protein deposition
by 58% (P < 0.001).
Conclusion. Aldosterone remodels human endothelium in
vitro. Cells increase in size and stiffness. Protein leakage through
intercellular gaps could be caused by the increased apical mem-
brane tension. The increase in cell rigidity could trigger en-
dothelial dysfunction observed in hyperaldosteronism.
Aldosterone acts not only on epithelial cells of kid-
ney and colon but also at nonepithelial sites in the brain,
heart, and vasculature. A growing number of studies in-
dicate that aldosterone plays a major role in the develop-
ment of heart failure, myocardial fibrosis, and endothelial
dysfunction [1]. By means of atomic force microscopy
(AFM), a nanotechnique that allows to measure single
cell volume independent of cell shape, apical endothe-
lial cell surface, and membrane tension, we addressed
the question of aldosterone-induced structural and func-
tional remodeling of the endothelium.
METHODS
Culture of human umbilical venous endothelial cells
(HUVECs) [2, 3] and cell imaging by AFM of fixed cells
Key words: atomic force microscopy, cell stiffness, endothelial compli-
ance.
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in fluid [4] has been described in detail. For measure-
ments of cell stiffness [3, 5, 6] the AFM is used as a me-
chanical sensor. The AFM tip is pressed against the living
(nonfixed) cell so that the membrane is indented. At the
same time, the AFM cantilever that serves as a soft spring
(spring constant 0.01 N/m) is distorted. Force distance
curves quantify the force (pN) necessary to distort the
membrane for a given distance (nm). In order to evaluate
the nature and amount of material deposited underneath
the monolayer cells were removed from the solid support
by calcium chelation. Then, the solid support was scanned
in fluid by AFM and the deposited material quantified as
“mean surface roughness.” This value indicates the mean
height deviations of the deposited material in reference
to the substratum.
RESULTS
HUVECs maintain natural shape and volume when
fixed under physiologic conditions and scanned in liquid
[3]. Images in Figure 1 are representative examples. They
indicate a substantial increase in volume and apical mem-
brane surface of aldosterone-treated cells. Consequently,
the number of cells per defined area is reduced after hor-
mone treatment. Table 1 shows the statistical analysis.
According to the law of Laplace, the mechanical tension
of a spherical structure correlates positively with the ra-
dius. Since cells can be treated as segments of a sphere,
we measured the force necessary to indent the cell mem-
brane by a given distance. Indeed, we detected a 78%
(P < 0.001) increase of membrane tension (Table 1).
Close inspection of the HUVEC monolayer in liquid
disclosed gap formation between cells of the aldosterone-
treated monolayers (Fig. 1). The gaps were found
inhomogenously distributed in the monolayer. We hy-
pothesized that such structures could serve as paracel-
lular pathways for macromolecules traveling from the
apical to the basolateral side of the endothelium. There-
fore, in another series of experiments, we removed the
endothelial cells by exposure of the monolayer to the
calcium-chelating agent ethylenediaminetetraacetic acid
(EDTA). Then we scanned the coverslips and found ma-
terial deposited underneath the monolayer. Obviously,
macromolecules accumulated there after aldosterone
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Fig. 1. Atomic force microscopy (AFM) images of human umbilical venous endothelial cells (HUVECs) monolayers. Cells were exposed to either
the solvent (control) or 10 nmol/L aldosterone for 72 hours. Outlines indicate single cells. Cell size and stiffness increase with aldosterone exposure.
Intercellular gaps occur in response to the hormone.
Table 1. Remodeling of human endothelial cells in response to
aldosterone
Parameter Control Aldosterone Increase%
Single cell volume fl 1652 ± 63 1996 ± 161 18
(N = 10) (N = 10) (P < 0.01)
Apical cell surface lm2 1238 ± 52 2035 ± 170 64
(N = 10) (N = 10) (P < 0.001)
Cell stiffness pN/nm 6 ± 0.7 10 ± 1.2 78
(N = 10) (N = 14) (P < 0.01)
Mean roughness nm 1.4 ± 0.08 2.1 ± 0.07 56
(N = 9) (N = 9) (P < 0.001)
Aldosterone exposure was 72 hours. Mean roughness is a measure for the
amount of proteins deposited underneath the endothelial cell monolayer (mean
values ± SEM) (N = number of experiments). All data were obtained with
atomic force microscopy (AFM). P values indicate the level of significance
comparing mean data of the control and aldosterone experiments.
treatment (expressed as mean surface roughness in
Table 1). Short exposure to trypsin decreased the amount
of this material indicating that the detected matter con-
sisted of proteins.
DISCUSSION
Renal epithelium and vascular endothelium share cer-
tain properties: They both express mineralocorticoid
receptors [7, 8] and epithelial sodium channels [9]. More-
over, the endothelium responds to the epithelial sodium
channel blocker amiloride [10]. However, aldosterone
should not be considered to be just a hormone in charge
of the recruitment of sodium channels. Its proliferative
action on cells, particular on renal epithelium, has been
recently described [11]. Thus, numerous ion channels and
transporters are expected to be expressed in response
to aldosterone. This could explain the 18% increase of
endothelial volume [10] and the 64% increase of the
apical endothelial membrane surface. Furthermore, al-
dosterone exposure facilitates intercellular gap forma-
tion. Due to the gap size in the range of micrometers they
could serve as irregular diffusion pathways for large par-
ticles. This should alter the selectivity of the endothelial
filter. Indeed, large particles, most likely proteins/protein
complexes, accumulate more readily underneath the
monolayer. This is indicated by the dramatic increase
in “roughness” measurements of the cell substratum af-
ter removal of the cells. It is tempting to assume that
aldosterone-induced gaps allow large proteins and even
supramolecular structures to pass the endothelium in an
irregular “nonselective” manner.
Another observation is the increase in endothelial
cell stiffness with aldosterone treatment. This could be
the result of the increased apical membrane tension in
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Fig. 2. Schematic on the structural and functional changes in endothe-
lium induced by aldosterone. Cells grow in size and surface while the
number of cells per area of endothelium diminishes. Cell flattening
causes increased membrane tension and intercellular gap formation.
Cells get stiff and unselective endothelial leaks occur.
hormone treated cells (Fig. 2). An increase in cell stiff-
ness is expected according to the law of Laplace [12].
Membrane tension should increase with increasing
cell diameter. Besides this biophysical explanation
aldosterone-induced stiffness of endothelial cells could
be caused also by the modulation of NADH/NADPH-
dependent oxidases [13] and/or the nitric oxide synthase
pathway [14]. Presumably, aldosterone-triggered forma-
tion of superoxide anion, a potent scavenger of nitric
oxide, could stiffen endothelial cells by yet unknown
molecular mechanisms.
It is tempting to speculate that during aldosterone ex-
posure a small percentage of cell-to-cell contacts cannot
withstand the increased mechanical forces (i.e., mem-
brane tension) and, therefore, develop gaps. Such a
nonselective pathway could contribute to endothelial
dysfunction observed in hyperaldosteronism [15].
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